METHYCLOTHIAZIDE AND DESERPIDINE Drug Patent Profile
✉ Email this page to a colleague
When do Methyclothiazide And Deserpidine patents expire, and when can generic versions of Methyclothiazide And Deserpidine launch?
Methyclothiazide And Deserpidine is a drug marketed by Watson Labs and is included in two NDAs.
The generic ingredient in METHYCLOTHIAZIDE AND DESERPIDINE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METHYCLOTHIAZIDE AND DESERPIDINE?
- What are the global sales for METHYCLOTHIAZIDE AND DESERPIDINE?
- What is Average Wholesale Price for METHYCLOTHIAZIDE AND DESERPIDINE?
Summary for METHYCLOTHIAZIDE AND DESERPIDINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | METHYCLOTHIAZIDE AND DESERPIDINE at DailyMed |
US Patents and Regulatory Information for METHYCLOTHIAZIDE AND DESERPIDINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | METHYCLOTHIAZIDE AND DESERPIDINE | deserpidine; methyclothiazide | TABLET;ORAL | 088486-001 | Aug 10, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Watson Labs | METHYCLOTHIAZIDE AND DESERPIDINE | deserpidine; methyclothiazide | TABLET;ORAL | 088452-001 | Aug 10, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
